2005
DOI: 10.1016/j.jmb.2005.02.006
|View full text |Cite
|
Sign up to set email alerts
|

Molecular Crowding Limits the Role of Fetal Hemoglobin in Therapy for Sickle Cell Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
27
0
1

Year Published

2006
2006
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 28 publications
(30 citation statements)
references
References 32 publications
2
27
0
1
Order By: Relevance
“…Acceleration of slow (transition state limited) protein Large increases in the rate of fiber formation by sickle cell hemoglobin (Rotter et al, 2005), actin associations (Minton, 1983;Minton, 2001a). (Drenckhahn and Pollard, 1986), tubulin (Herzog and Weber, 1978) and fibrin (Wilf et al, 1985).…”
Section: Relevance To Cell Biologymentioning
confidence: 99%
“…Acceleration of slow (transition state limited) protein Large increases in the rate of fiber formation by sickle cell hemoglobin (Rotter et al, 2005), actin associations (Minton, 1983;Minton, 2001a). (Drenckhahn and Pollard, 1986), tubulin (Herzog and Weber, 1978) and fibrin (Wilf et al, 1985).…”
Section: Relevance To Cell Biologymentioning
confidence: 99%
“…Therefore, Hb F plus such peptides might exhibit anti-sickling effects exceeding those of Hb F alone. This has important implications for gene therapy for sickle cell disease, since anti-polymerization induced by these peptides and Hb F may possibly be accomplished by completely different mechanisms; inhibition by the former via direct interaction with Hb S, and the latter by reduction in Hb S concentration via formation of hybrids which are excluded from Hb S polymers (19). We are screening for such peptides and will evaluate their anti-polymerization properties under near physiological conditions.…”
Section: Discussionmentioning
confidence: 99%
“…Such nuclei can be formed either in bulk solution from HbS free monomers (the so-called homogeneous nucleation pathway), or on pre-existing polymers (the heterogeneous nucleation pathway). The model successfully describes the polymerization of fully deoxygenated HbS (i) in the 3-6 mM concentration (Ferrone et al 1985b), (ii) at different temperatures (15-35°C; Ferrone et al1985b), and (iii) in the presence of varying, clinically relevant, amounts of HbF (Rotter et al 2005a). …”
Section: The Double Nucleation Model Of Hbs Polymerizationmentioning
confidence: 99%